Pharming Group (PHG) Ratios
Pharming Group Ratios
DE:PHG's free cash flow for Q3 2026 was $32.27M. For the 2026 fiscal year, DE:PHG's free cash flow was decreased by $-279.95K and operating cash flow was $32.55M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.59 | 3.77 | 4.06 | 4.65 | 5.33 |
| Quick Ratio | 2.03 | 3.02 | 3.33 | 3.94 | 4.75 |
| Cash Ratio | 1.26 | 0.74 | 0.79 | 3.47 | 4.10 |
| Solvency Ratio | 0.06 | 0.02 | 0.02 | 0.12 | 0.17 |
| Operating Cash Flow Ratio | 0.47 | -0.02 | -0.22 | 0.38 | 0.81 |
| Short-Term Operating Cash Flow Coverage | 10.25 | -0.42 | -9.49 | 12.70 | 20.14 |
| Net Current Asset Value | $ 76.58M | $ 103.05M | $ 72.27M | $ 56.34M | $ 45.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.23 | 0.28 | 0.37 | 0.39 | 0.41 |
| Debt-to-Equity Ratio | 0.42 | 0.51 | 0.78 | 0.81 | 0.84 |
| Debt-to-Capital Ratio | 0.29 | 0.34 | 0.44 | 0.45 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.25 | 0.26 | 0.38 | 0.39 | 0.42 |
| Financial Leverage Ratio | 1.80 | 1.81 | 2.12 | 2.08 | 2.06 |
| Debt Service Coverage Ratio | 1.52 | 1.00 | 1.46 | 4.52 | 5.18 |
| Interest Coverage Ratio | 1.95 | -0.99 | -0.90 | 3.40 | 2.20 |
| Debt to Market Cap | 0.08 | 0.12 | 0.18 | 0.15 | 0.20 |
| Interest Debt Per Share | 1.77 | 1.82 | 2.70 | 2.08 | 1.92 |
| Net Debt to EBITDA | -0.87 | 3.52 | 11.12 | -1.21 | -0.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 87.90% | 88.09% | 89.72% | 91.46% | 89.37% |
| EBIT Margin | 6.27% | 0.08% | -2.47% | 9.89% | 14.67% |
| EBITDA Margin | 9.25% | 5.49% | 4.03% | 16.31% | 24.53% |
| Operating Profit Margin | 5.55% | -2.90% | -2.20% | 8.87% | 6.82% |
| Pretax Profit Margin | 3.42% | -2.86% | -4.90% | 7.29% | 11.60% |
| Net Profit Margin | 0.76% | -3.98% | -4.30% | 6.65% | 8.04% |
| Continuous Operations Profit Margin | 0.67% | -3.98% | -4.30% | 6.65% | 8.04% |
| Net Income Per EBT | 22.19% | 139.44% | 87.81% | 91.24% | 69.31% |
| EBT Per EBIT | 61.52% | 98.50% | 222.98% | 82.20% | 170.18% |
| Return on Assets (ROA) | 0.57% | -2.96% | -2.28% | 3.21% | 4.03% |
| Return on Equity (ROE) | 1.03% | -5.36% | -4.82% | 6.68% | 8.29% |
| Return on Capital Employed (ROCE) | 5.44% | -2.64% | -1.40% | 4.98% | 3.87% |
| Return on Invested Capital (ROIC) | 1.05% | -2.59% | -1.21% | 4.48% | 2.65% |
| Return on Tangible Assets | 0.78% | -3.49% | -2.69% | 3.90% | 5.10% |
| Earnings Yield | 0.23% | -1.77% | -1.40% | 1.50% | 2.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.88 | 5.92 | 5.76 | 8.12 | 7.21 |
| Payables Turnover | 0.43 | 3.50 | 1.57 | 2.01 | 2.78 |
| Inventory Turnover | 0.70 | 0.64 | 0.44 | 0.41 | 0.77 |
| Fixed Asset Turnover | 15.70 | 12.76 | 7.33 | 5.25 | 6.00 |
| Asset Turnover | 0.75 | 0.74 | 0.53 | 0.48 | 0.50 |
| Working Capital Turnover Ratio | 1.90 | 1.37 | 1.08 | 0.98 | 1.12 |
| Cash Conversion Cycle | -275.71 | 532.02 | 653.18 | 742.73 | 390.93 |
| Days of Sales Outstanding | 53.07 | 61.62 | 63.41 | 44.97 | 50.64 |
| Days of Inventory Outstanding | 520.48 | 574.57 | 821.73 | 879.68 | 471.49 |
| Days of Payables Outstanding | 849.26 | 104.17 | 231.95 | 181.92 | 131.19 |
| Operating Cycle | 573.55 | 636.19 | 885.13 | 924.65 | 522.13 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.77 | -0.03 | -0.26 | 0.27 | 0.43 |
| Free Cash Flow Per Share | 0.76 | -0.04 | -0.29 | 0.25 | 0.24 |
| Dividend Paid and CapEx Coverage Ratio | 72.46 | -2.26 | -11.82 | 11.36 | 2.26 |
| Capital Expenditure Coverage Ratio | 72.46 | -2.26 | -11.82 | 11.36 | 2.26 |
| Operating Cash Flow Coverage Ratio | 0.47 | -0.02 | -0.10 | 0.13 | 0.23 |
| Operating Cash Flow to Sales Ratio | 0.15 | -0.01 | -0.07 | 0.11 | 0.19 |
| Free Cash Flow Yield | 4.28% | -0.39% | -2.50% | 2.25% | 3.07% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 441.75 | -57.22 | -71.20 | 66.58 | 43.08 |
| Price-to-Sales (P/S) Ratio | 3.35 | 2.26 | 3.06 | 4.43 | 3.46 |
| Price-to-Book (P/B) Ratio | 4.55 | 3.03 | 3.43 | 4.45 | 3.57 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 23.36 | -258.67 | -40.02 | 44.45 | 32.62 |
| Price-to-Operating Cash Flow Ratio | 23.03 | -373.38 | -43.40 | 40.54 | 18.21 |
| Price-to-Earnings Growth (PEG) Ratio | -3.60 | -2.68 | 0.38 | -3.92 | -0.75 |
| Enterprise Value Multiple | 35.36 | 44.60 | 87.15 | 25.94 | 13.51 |
| Enterprise Value | 1.23B | 753.42M | 860.79M | 869.82M | 658.88M |
| EV to EBITDA | 35.36 | 44.60 | 87.15 | 25.94 | 13.51 |
| EV to Sales | 3.27 | 2.45 | 3.51 | 4.23 | 3.31 |
| EV to Free Cash Flow | 22.80 | -280.82 | -45.87 | 42.47 | 31.19 |
| EV to Operating Cash Flow | 22.48 | -405.34 | -49.75 | 38.73 | 17.41 |
| Tangible Book Value Per Share | 1.98 | 2.40 | 2.25 | 1.57 | 1.24 |
| Shareholders’ Equity Per Share | 3.88 | 3.32 | 3.33 | 2.48 | 2.20 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.80 | -0.39 | 0.12 | 0.09 | 0.31 |
| Revenue Per Share | 5.27 | 4.47 | 3.73 | 2.49 | 2.27 |
| Net Income Per Share | 0.04 | -0.18 | -0.16 | 0.17 | 0.18 |
| Tax Burden | 0.22 | 1.39 | 0.88 | 0.91 | 0.69 |
| Interest Burden | 0.55 | -34.66 | 1.99 | 0.74 | 0.79 |
| Research & Development to Revenue | 0.27 | 0.28 | 0.28 | 0.26 | 0.35 |
| SG&A to Revenue | 0.31 | 0.33 | 0.33 | 0.30 | 0.23 |
| Stock-Based Compensation to Revenue | 0.04 | 0.04 | 0.04 | 0.03 | 0.05 |
| Income Quality | 4.26 | 0.21 | 1.44 | 1.50 | 1.64 |
Currency in EUR